Sivextro and Drug ineffective - a phase IV clinical study of FDA data

Summary:

Drug ineffective is reported as a side effect among people who take Sivextro (tedizolid phosphate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cefazolin, and have Staphylococcal infection.

The phase IV clinical study analyzes which people have Drug ineffective when taking Sivextro. It is created by eHealthMe based on reports of 586 people who have side effects when taking Sivextro from the FDA, and is updated regularly.

What is Sivextro?

Sivextro has active ingredients of tedizolid phosphate. eHealthMe is studying from 586 Sivextro users. Check the latest studies of Sivextro.

What is Drug ineffective?

Drug ineffective is found to be associated with 4,081 drugs and 5,193 conditions by eHealthMe. Check the latest studies of Drug ineffective.

On Aug, 06, 2026

586 people reported to have side effects when taking Sivextro.
Among them, 33 people (5.63%) have Drug ineffective.

Among these 33 people:

How long have people been on Sivextro when they have Drug ineffective? *

What is the gender of people who have Drug ineffective when taking Sivextro? *

female: 57.69 %
male: 42.31 %

What is the age of people who have Drug ineffective when taking Sivextro? *

What are other drugs people take besides Sivextro? *

What are other side effects people have besides Drug ineffective? *

Glomerular Filtration Rate Abnormal: 10 people, 30.30%
Gait Disturbance: 10 people, 30.30%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 10 people, 30.30%
Fall: 10 people, 30.30%
Adverse Event: 6 people, 18.18%
Blood Creatinine Increased: 6 people, 18.18%
Blood Creatinine Abnormal: 4 people, 12.12%
Swelling: 2 people, 6.06%
Acute Kidney Failure: 1 person, 3.03%
Capnocytophaga Infection (bacterial infection): 1 person, 3.03%

What are the existing conditions these people have? *

Staphylococcal Infection (an infection with staphylococcus bacteria): 14 people, 42.42%
Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 30.30%
Cellulitis (infection under the skin): 6 people, 18.18%
Wound Infection: 2 people, 6.06%
Skin Infection: 2 people, 6.06%
Infection: 2 people, 6.06%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 2 people, 6.06%
Wound Infection Staphylococcal: 1 person, 3.03%
Soft Tissue Infection: 1 person, 3.03%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Sivextro and have Drug ineffective?

- Check whether Drug ineffective is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sivextro:

Sivextro (586 reports)

Drug ineffective treatments and more:

Drug ineffective (1,349,510 reports)

Browse all side effects of Sivextro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug ineffective:

Drug ineffective (4,082 drugs)

Browse all the conditions that are associated with Drug ineffective:

Drug ineffective (5,193 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tedizolid phosphate (the active ingredients of Sivextro) and Sivextro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.